Trial Profile
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2024
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Acronyms EVOKE-RT
- 28 Feb 2024 Status changed from recruiting to completed.
- 07 Nov 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 07 Nov 2022 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.